PMC:7600245 / 3457-3654 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T20","span":{"begin":96,"end":104},"obj":"Disease"}],"attributes":[{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"tients with severe disease [9]. Furthermore, favipiravir has been approved for the treatment of COVID-19 in the hospital settings in few countries [10]. Moreover, dexamethasone as an anti-inflammat"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T9","span":{"begin":57,"end":60},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"tients with severe disease [9]. Furthermore, favipiravir has been approved for the treatment of COVID-19 in the hospital settings in few countries [10]. Moreover, dexamethasone as an anti-inflammat"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T15","span":{"begin":45,"end":56},"obj":"Chemical"},{"id":"T16","span":{"begin":163,"end":176},"obj":"Chemical"}],"attributes":[{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_41879"}],"text":"tients with severe disease [9]. Furthermore, favipiravir has been approved for the treatment of COVID-19 in the hospital settings in few countries [10]. Moreover, dexamethasone as an anti-inflammat"}

{"project":"LitCovid-sentences","denotations":[{"id":"T26","span":{"begin":32,"end":152},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"tients with severe disease [9]. Furthermore, favipiravir has been approved for the treatment of COVID-19 in the hospital settings in few countries [10]. Moreover, dexamethasone as an anti-inflammat"}

{"project":"LitCovid-PubTator","denotations":[{"id":"68","span":{"begin":45,"end":56},"obj":"Chemical"},{"id":"69","span":{"begin":163,"end":176},"obj":"Chemical"},{"id":"72","span":{"begin":96,"end":104},"obj":"Disease"}],"attributes":[{"id":"A68","pred":"tao:has_database_id","subj":"68","obj":"MESH:C462182"},{"id":"A69","pred":"tao:has_database_id","subj":"69","obj":"MESH:D003907"},{"id":"A72","pred":"tao:has_database_id","subj":"72","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tients with severe disease [9]. Furthermore, favipiravir has been approved for the treatment of COVID-19 in the hospital settings in few countries [10]. Moreover, dexamethasone as an anti-inflammat"}